Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.

Leonard B, Taylor D.

J Psychopharmacol. 2010 Aug;24(8):1143-52. doi: 10.1177/0269881109349835. Epub 2010 Feb 10. Review.

2.

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

Kennedy SH, Andersen HF, Lam RW.

J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228.

3.

Escitalopram versus citalopram: the surprising role of the R-enantiomer.

Sánchez C, Bøgesø KP, Ebert B, Reines EH, Braestrup C.

Psychopharmacology (Berl). 2004 Jul;174(2):163-76. Review.

PMID:
15160261
4.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
5.

Escitalopram.

Aronson S, Delgado P.

Drugs Today (Barc). 2004 Feb;40(2):121-31. Review.

PMID:
15045034
6.

Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

Lam RW, Lönn SL, Despiégel N.

Int Clin Psychopharmacol. 2010 Jul;25(4):199-203. doi: 10.1097/YIC.0b013e32833948d8.

PMID:
20357664
8.

Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.

Hirschfeld RM, Vornik LA.

J Clin Psychiatry. 2004;65 Suppl 4:46-52. Review.

9.

Escitalopram in the treatment of major depressive disorder: a meta-analysis.

Kennedy SH, Andersen HF, Thase ME.

Curr Med Res Opin. 2009 Jan;25(1):161-75. doi: 10.1185/03007990802622726 .

PMID:
19210149
10.

[Mechanisms of action of antidepressants: new data from Escitalopram].

Fabre V, Hamon M.

Encephale. 2003 May-Jun;29(3 Pt 1):259-65. French.

PMID:
12876551
11.

Spotlight on the pharmacoeconomics of escitalopram in depression.

Croom KF, Plosker GL.

CNS Drugs. 2004;18(7):469-73. Review.

PMID:
15139801
12.

Escitalopram versus other antidepressive agents for depression.

Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R, Barbui C.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006532. doi: 10.1002/14651858.CD006532.pub2. Review.

13.

[Escitalopram and citalopram: the unexpected role of the R-enantiomer].

Jacquot C, David DJ, Gardier AM, Sánchez C.

Encephale. 2007 Mar-Apr;33(2):179-87. Review. French.

PMID:
17675913
14.

Duloxetine versus other anti-depressive agents for depression.

Cipriani A, Koesters M, Furukawa TA, Nosè M, Purgato M, Omori IM, Trespidi C, Barbui C.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD006533. doi: 10.1002/14651858.CD006533.pub2. Review.

15.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
16.

A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?

Sanchez C, Reines EH, Montgomery SA.

Int Clin Psychopharmacol. 2014 Jul;29(4):185-96. doi: 10.1097/YIC.0000000000000023. Review.

17.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
18.

[Efficacy of escitalopram and severity of depression: new data].

Spadone C.

Encephale. 2009 Dec;35(6):577-85. doi: 10.1016/j.encep.2009.10.004. Review. French.

PMID:
20004289
19.

Escitalopram: a review of its use in the management of major depressive disorder in adults.

Garnock-Jones KP, McCormack PL.

CNS Drugs. 2010 Sep;24(9):769-96. doi: 10.2165/11204760-000000000-00000. Review.

PMID:
20806989
20.

Spotlight on escitalopram in the management of major depressive disorder.

Murdoch D, Keam SJ.

CNS Drugs. 2006;20(2):167-70.

PMID:
16478291

Supplemental Content

Support Center